1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPilot Funding Program is sponsored by Florida Center for Brain Tumor Research (FCBTR). The FCBTR funds competitive pilot research projects for cutting-edge scientific proposals that aim to lead to the discovery of brain tumor cures and improved treatment modalities.
Get alerted about grants like this
Get emailed when new opportunities from “Florida Center for Brain Tumor Research (FCBTR)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Pilot Funding » Florida Center for Brain Tumor Research » College of Medicine » University of Florida Since 2006, FCBTR has been funding competitive pilot research projects for cutting edge scientific proposals, which hope to lead the way to discovery of brain tumor cures and the development of improved brain tumor treatment modalities.
FCBTR offers a proven track record of disbursing RFA’s to all brain tumor scientists across the state, receiving an average of 15 submissions per year from multiple Florida public and private institutions.
FCBTR provides funding to 3 or 4 of those per year based on a rating scale, as follows: The FCBTR is mandated by the State of Florida to equitably distribute $250,000 per year, to the top grants, reviewed and selected by an out-of-state external advisory board of leaders in the field. There were 100 submissions over the past 8 years, with funding provided to 20 of those pilot grants.
Awardees hailed from Florida research institutions such as UF (18 awards), FSU (2 awards), Moffit (4 awards), Scripps (2 awards), Mayo (4 awards), Univ. of Miami(4 awards) and have repeatedly borne success and return on investment by means of data acquisition that improved their competitiveness for extramural funding, resulting in NIH and other peer reviewed grants of substantial size and scope.
Many of the investigators brought new concepts, approaches and/or paradigms to brain tumor research and several of the funded projects used their results as preliminary data to successfully apply for other peer reviewed funding. The $2,000,000 in awards distributed by FCBTR over just the last 8 years, has returned reported research grants totaling approximately $40,000,000 to the state of Florida academic institutions.
The return on investment for the State of Florida was over $38,000,000. Publications from these awardees have exceeded over 240 manuscripts related to brain tumor research and many pivoting from the FCBTR pilot studies. At least 4 new INDs and 16 US Patents have been approved based on the pilot research data program.
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Brain tumor researchers across Florida at public and private research institutions. Confirm the full requirements in the official notice before applying.
The current listing shows $250,000 annually distributed across 3-4 grants. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Pilot Funding Program is funded by Florida Center for Brain Tumor Research (FCBTR). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Florida. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
ARPA-H's HEARING program (ARPA-H-SOL-26-154) — Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy — held its Proposers' Day on June 8, 2026 and set Solution Summary deadlines for June 29 with Full Proposals due August 14. Single prime awardee, multiple Other Transaction Agreements, three integrated technical areas spanning intracortical recording and stimulation devices, wearable dynamic sound modulators, and AI-based auditory read/write algorithms. The first phase runs 18 months; the full effort runs 4.5 years through first-in-human clinical studies. For neurotech teams that have spent a decade in cochlear-implant or visual-prosthesis space, this is the moment the federal government bet on auditory cortex over the cochlea.
Read articleA Nature poll finds three-quarters of American scientists are considering working abroad. ERC applications from U.S. researchers have tripled. France and the EU pledged €500 million to recruit them. Inside the brain drain reshaping global science — and what it means for grant strategy.
Read article